FDA
-
-
-
-
-
-
-
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
-
-
-
-
-
-
-
Enveric Biosciences to Participate in a Panel Discussion at Needham’s Virtual Psychedelics Forum
-
-
-
-
-
-
-
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
-
-
-
-
-
-
-
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
-
-
-
-
-
-
-
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman
-
-
-
-
-
-
-
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
-
-
-
-
-
-
-
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
-
326,710 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

